Comanche Biopharma Email Format
Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees
Comanche Biopharma is a pharmaceutical manufacturing company based in Concord, Massachusetts (01742), United States. It is developing an investigational siRNA medicine for the treatment of preterm preeclampsia. The company employs approximately 11 to 50 people. In December 2025, it announced leadership appointments, naming Richard Colvin as Global Head of Research and Development and John McHutchison as Chairman and Director of Comanche Biopharma Australia. Public disclosures include a 2024 Series B financing and a US FDA Fast Track designation for CBP-4888, reflecting milestones in its development program.